Preclinical, Clinical, and Translational Sciences

Symposium: Special Considerations for Patient Populations in Clinical Trials

Moderator(s)

• 

  Viera Lukacova, PhD

  Chief Scientist
  Simulations Plus, Inc.
  Santa Clarita, California

Presentations:

• 9:00 AM - 9:30 AM CT

  Hepatic Impairment and the Differential Effects on Drug Clearance Mechanisms
  

  Speaker: Manthena V. Varma, PhD – Pfizer Inc
• 9:30 AM - 10:00 AM CT

  AI in Designing and Delivering Clinical Trials for Specific Populations
  

  Speaker: Raja B. Velagapudi, PhD (he/him/his) – Tolmar Inc
• 10:00 AM - 10:30 AM CT

  Trial Design for Obese: Right Compound, Right Dose, Right Patient
  

  Speaker: Maxime Le Merdy, Ph.D. – Simulations Plus, Inc.
• 10:30 AM - 11:00 AM CT

  Model-Informed Design of Clinical Trial in Patients with Renal Impairment
  

  Speaker: Viera Lukacova, PhD – Simulations Plus, Inc.